Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Sepsis Diagnostic Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Sepsis Diagnostic Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Sepsis Diagnostic Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Sepsis Diagnostic Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 21 Jun 2021
  • Report ID: HLT 00223
  • Pages: 178
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

According to a study published by Insure Insights, the sepsis diagnostic market is estimated to grow at a CAGR of 9.8% during the forecast period. Sepsis is a life-threatening condition caused by the uncontrolled response of the body to an infection. Normally, the body releases chemicals into the bloodstream to fight against antigens. Sepsis occurs when these chemicals are released in an uncontrolled manner and damage multiple organ systems. If sepsis progresses to septic shock, blood pressure drops dramatically, leading to death. Sepsis generally occurs in the geriatric population, people suffering from chronic diseases such as diabetes, kidney or lung conditions, pregnant women, and infants.

Top Driver: Rising Prevalence of Sepsis and Hospital Acquired Infections

The major factor driving the global sepsis diagnostic market is the rising prevalence of sepsis around the world. According to the World Health Organization (WHO), 2018 statistics, sepsis affected around 30 million people in the world, and more than 3 million newborns and 1.2 million children suffer from sepsis globally each year. In addition, the data provided by the Centers for Disease Control and Prevention (CDC), more than 1.5 million people in the U.S. suffer from sepsis annually, and around 2,50,000 Americans die each year due to sepsis. This has encouraged the government to carry out a diagnosis for sepsis at a huge scale every year.

Other factors, such as the growing geriatric population, increasing health awareness, and rising prevalence of chronic disorders, are the other factors fueling the growth of the global sepsis diagnostic market. Besides, a high incidence of hospital-acquired infection is the prominent factor anticipated to stimulate the sepsis diagnostic market during the forecast period.

Laboratory Testing Anticipated to Witness Growth During the Forecast Period

Based on the diagnostic type, the sepsis diagnostic market has been segmented into laboratory testing and PoC testing. The laboratory testing segment accounts for the largest market share and is anticipated to continue its dominance during the forecast period owing to the rising number of blood culture tests conducted in the laboratories. The rising number of laboratories and healthcare expenditure to develop advanced instruments in developed as well as in developing countries is are estimated to foster the laboratory testing segment.

By product, the market is segmented into instruments, assay kits, blood culture media, and others. Blood culture media holds the largest market share owing to its cost-effectiveness and is considered as the gold standard.

Based on the technology, the market is segmented into immunoassay, microbiology, molecular diagnostic, and others. The molecular diagnostic is anticipated to witness growth in the near future, owing to its high accuracy and sensitivity.

Based on the pathogen, the market has been segmented into fungal sepsis, bacterial sepsis, and others. A high prevalence of bacteria is attributing to the growth of the bacterial sepsis segment.

Rising Prevalence of Sepsis to Benefit North America Market

North America holds the largest market share in the global sepsis diagnostic market and is estimated to show a similar trend during the forecast period. One of the primary factors responsible is the rising incidence of sepsis in countries such as the United States and Canada, thereby encouraging the government for rapid diagnosis. According to the CDC statistics in 2018, sepsis affects more than a million Americans every year and leads to 15% to 30% deaths in the United States. The rising prevalence of sepsis is attributed to a few factors, such as the growing geriatric population, rising incidence of incurable infections, and the majority of the population who have undergone an organ transplant.

Players to Focus on Strategic Acquisition and Product Development 

Some of the prominent players operating in the global sepsis diagnosis market are bioMérieux SA, Beckman Coulter, Inc., Becton, Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific, Inc.

Beckman Coulter: In May 2020, Beckman Coulter announced an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to Beckman Coulter, in collaboration with Dascena, Inc., for additional advanced research and development toward optimization of a machine-learning-based sepsis diagnostic and prediction algorithm to include assessing its use with coronavirus (COVID-19) patients.

Sysmex Corporation: In September 2019, Sysmex Corporation introduced the HISCL Presepsin Assay Kit for Sepsis Testing. The assay kit can be used with its Automated Immunoassay System HISCL-5000/2000i/800 for immunochemistry testing (HISCL-Series). This reagent is used for measuring levels of presepsin, a major test parameter for bacterial sepsis.

Scope of the Report

By Technology

  • Molecular diagnostic
  • Immunoassay
  • Microbiology
  • Others

By Product

  • Instruments
  • Assay kits
  • Blood culture media
  • Others

By Diagnostic method

  • Laboratory testing
  • PoC testing

By Pathogen

  • Fungal sepsis
  • Bacterial sepsis
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Table of Content

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Sepsis Diagnostic Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Sepsis Diagnostic Market -Industry Snapshots

6.1             Overview

6.1.1          Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Sepsis Diagnostic Market Analysis, by Technology

7.1             Overview

7.2             Key Findings for Sepsis Diagnostic Market- By Technology

7.2.1          Sepsis Diagnostic Market- Molecular diagnostic

7.2.2          Sepsis Diagnostic Market- Immunoassay

7.2.3          Sepsis Diagnostic Market- Microbiology

7.2.4          Sepsis Diagnostic Market- Others

Chapter 8           Global Sepsis Diagnostic Market Analysis, by Product

8.1             Overview

8.2             Key Findings for Sepsis Diagnostic Market- By Product

8.2.1          Sepsis Diagnostic Market- Instruments

8.2.2          Sepsis Diagnostic Market- Assay kits

8.2.3          Sepsis Diagnostic Market- Blood culture media

8.2.4          Sepsis Diagnostic Market- Others

Chapter 9           Global Sepsis Diagnostic Market Analysis, by Diagnostic method

9.1             Overview

9.2             Key Findings for Sepsis Diagnostic Market- By Diagnostic method

9.2.1          Sepsis Diagnostic Market- Laboratory testing

9.2.2          Sepsis Diagnostic Market- PoC testing

Chapter 10       Global Sepsis Diagnostic Market Analysis, by Pathogen

10.1           Overview

10.2           Key Findings for Sepsis Diagnostic Market- By Pathogen

10.2.1       Sepsis Diagnostic Market- Fungal sepsis

10.2.2       Sepsis Diagnostic Market- Bacterial sepsis

10.2.3       Sepsis Diagnostic Market- Others

Chapter 11       Sepsis Diagnostic Market Analysis by Region

11.1           Key Findings for Sepsis Diagnostic Market- By region

11.2           Overview

11.2.1       Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028

11.2.2       Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028

11.2.3       Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028

11.2.4       Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028

11.3           Sepsis Diagnostic Market – North America

11.3.1       Overview

11.3.2       U.S.

11.3.3       Canada

11.3.4       Mexico

11.3.5       North America Market, By Technology

11.3.6       North America Market, By Product

11.3.7       North America Market, By Diagnostic method

11.3.8       North America Market, By Pathogen

11.4           Sepsis Diagnostic Market – Europe

11.4.1       Overview

11.4.2       Germany

11.4.3       United Kingdom

11.4.4       France

11.4.5       Italy

11.4.6       Rest Of Europe

11.4.7       Europe Market, By Technology

11.4.8       Europe Market, By Product

11.4.9       Europe market by, Diagnostic method

11.4.10     Europe Market, By Pathogen

11.5           Sepsis Diagnostic Market – Asia Pacific

11.5.1       Overview

11.5.2       China

11.5.3       Japan

11.5.4       India

11.5.5       Rest of APAC

11.5.6       Asia Pacific Market, By Technology

11.5.7       Asia Pacific Market, By Product

11.5.8       Asia Pacific Market, By Diagnostic method

11.5.9       Asia Pacific Market, By Pathogen

11.6           Sepsis Diagnostic Market – SAMEA

11.6.1       Overview

11.6.2       Middle East & Africa (MEA)

11.6.3       South America

11.6.4       Rest Of World

11.6.5       South America, Middle East and Africa Market, By Technology

11.6.6       South America, Middle East and Africa Market, By Product

11.6.7       South America, Middle East and Africa Market, By Diagnostic method

11.6.8       South America, Middle East and Africa Market, By Pathogen

Chapter 12       Market Competition Analysis

12.1           Market Share/Positioning Analysis

12.1.1       Market Positioning of Key Vendors, 2019

12.1.2       Key Strategies Adopted by the Leading Players

12.1.3       Recent Developments

Chapter 13       Company Profiles- Snapshot

13.1           bioMérieux SA

13.1.1       Business Fundamentals

13.1.2       Financial Snapshots

13.1.3       Product Portfolio

13.1.4       Recent Developments

13.2           Beckman Coulter, Inc.

13.3           Becton, Dickinson and Company

13.4           Sysmex Corporation

13.5           F. Hoffmann-La Roche AG

13.6           Thermo Fisher Scientific, Inc.

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 14       Appendix

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report